FDA Uncovers Manufacturing Issues at Sun Pharma Facility

FDA inspectors found dangerous breakdowns in drugmaking at a Sun Pharma factory in India, raising concerns about drug safety for American consumers.

Sun Pharma Settles Litigation, Launches Anti-Baldness Drug

Sun Pharmaceutical Industries Ltd announced a settlement with Incyte Corporation regarding LEQSELVI litigation, leading to the launch of LEQSELVI for severe alopecia areata treatment in the United States.

Short Sellers Crucial for Market Efficiency : Nithin Kamath

Lack of short selling in Indian markets causing distortions, Zerodha CEO advocates for simplification to improve price discovery and market efficiency.

Wockhardt Exits US Generics, Focuses on Antibiotics and Insulin

Wockhardt exits loss-making US generics business, shifts focus to drug discovery and insulin portfolios, aiming to improve profits and target emerging markets.

India Approves Eli Lilly’s Diabetes and Obesity Drug

India’s drug regulator approved Eli Lilly’s Mounjaro KwikPen for managing type 2 diabetes and obesity, offering a convenient weekly administration option.

Quiet Revolution: Southeast Asia's Human-Centered AI Transformation

Southeast Asia is shaping the AI landscape through everyday adaptation, creativity, and ethical development, emphasizing prompt-based discovery and the vital role of mentorship in guiding innovation and leadership.

Mankind Pharma Licenses Advanced Cancer Drug for Indian Market

Mankind Pharma partners with Innovent Biologics to launch sintilimab, an advanced PD-1 immunotherapy, in India to improve cancer treatment outcomes.

Bombay High Court Rules Against Hindustan Coca-Cola in Adulteration Case

Hindustan Coca-Cola loses plea to dismiss a 14-year-old case over adulterated beverage sales, following FDA's discovery of fibrous materials in 'Canada Dry' bottles in 2001.

Earth's Hidden Hydrogen Reserves Hold Key to Clean Energy Future

Discovery of vast geologic hydrogen reserves could revolutionize energy production and help combat climate change, but extraction challenges remain.